Results 201 to 210 of about 29,185 (239)

Targeting of Kaposi's sarcoma-associated herpesvirus by immunotoxins directed against the viral G protein-coupled receptor, ORF74.

Biomed Pharmacother
Kildedal DF, Drzazga AK, Sharma A, Berg C, Winther AN, Krogh-Hansen L, Gustavsson M, Kragelund BB, Våbenø J, Lagunoff M, Tsutsumi N, Kledal TN, Jeppesen MG, Rosenkilde MM.   +13 more
europepmc   +1 more source

The Kaposi's sarcoma-associated herpesvirus TBP mimic uses a noncanonical DNA-binding mode to promote viral late gene transcription. [PDF]

Nucleic Acids Res
Llacsahuanga-Allcca LE, Didychuk AL, Rodríguez-Vargas A, Glaunsinger BA.   +3 more
europepmc   +1 more source

Topical Sirolimus 0.1% as Off-Label Treatment of Kaposi's Sarcoma. [PDF]

Dermatol Pract Concept
Tancredi V, Licata G, Buononato D, Boccellino MP, Argenziano G, Giorgio CM.   +5 more
europepmc   +1 more source

Prognostic Factors and Long-Term Survival in Kaposi's Sarcoma Patients: Results from a 28-Year Retrospective Cohort. [PDF]

Medicina (Kaunas)
Hafızoğlu E, Bardakçı M, Ergun Y, Karahan I, Demirtaş Esmer D, Bayram D, Kos FT, Algın E, Bal O, Uncu D.   +9 more
europepmc   +1 more source

Kaposi's sarcoma immune reconstitution inflammatory syndrome: A forgotten entity nowadays. [PDF]

Indian J Sex Transm Dis AIDS
Cristina FR, Lorena VC, Tamara FS, Juan FC, Marta VN, Carlos PSV, Andrea GPL, Rafael CR, Esther QE.   +8 more
europepmc   +1 more source

Supplementary Material for: Kaposi’s Sarcoma in a kidney transplant recipient: A case report on Paclitaxel response

figshare admin karger, Ghabi H., Trabelsi Ayadi M, Zheni A., Tlili S., Rais R., BenHmida F., Mami I., Zouaghi M.K.   +8 more
openalex   +1 more source

Endothelial Cells Stably Infected with Recombinant Kaposi's Sarcoma-Associated Herpesvirus Display Distinct Viscoelastic and Morphological Properties. [PDF]

Cell Mol Bioeng
Shabangu MM, Blumenthal MJ, Sass DT, Lang DM, Schafer G, Franz T.   +5 more
europepmc   +1 more source

STARKAP Protocol: preliminary assessment of safety and tolerability of dostarlimab in combination antiretroviral therapy (cART)-refractory HIV associated Kaposi's Sarcoma. [PDF]

BMC Cancer
Fulgenzi CAM, Dalla Pria A, Leone AG, Martinez M, Del Peral EFM, Flores ME, Bower M, Pinato DJ.   +7 more
europepmc   +1 more source

Management and Future Therapeutic Perspectives of Classic Kaposi's Sarcoma: An Evidence-Based Review. [PDF]

Onco Targets Ther
Denaro N, Indini A, Brambilla L, Marzano AV, Garrone O, Tourlaki A.   +5 more
europepmc   +1 more source